Mesalamine API Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
SUMMARY
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Mesalamine API market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Mesalamine API market segmented into
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Mesalamine API market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Mesalamine API market segmented into
- Purity ? 97 %
- Purity ? 98 %
- Purity ? 99 %
- Mesalamine Tablets
- Mesalamine Capsules
- Others
- North America [U.S., Canada, Mexico]
- Europe [Germany, UK, France, Italy, Rest of Europe]
- Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
- South America [Brazil, Argentina, Rest of Latin America]
- Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
- Syntese A/S
- Corden Pharma Bergamo
- Ipca Laboratories
- Divis Laboratories
- Erregierre SpA
- Cambrex Corporation
- Ishita Active Pharma Ingredients
- Lasa Loboratory
- PharmaZell
- CTX Lifescience
- YC Biotech (Jiangsu)
- Xinxiang Tianfeng Fine Chemical
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL MESALAMINE API INDUSTRY
2.1 Summary about Mesalamine API Industry
2.2 Mesalamine API Market Trends
2.2.1 Mesalamine API Production & Consumption Trends
2.2.2 Mesalamine API Demand Structure Trends
2.3 Mesalamine API Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Purity ? 97 %
4.2.2 Purity ? 98 %
4.2.3 Purity ? 99 %
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Mesalamine Tablets
4.3.2 Mesalamine Capsules
4.3.3 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Purity ? 97 %
5.2.2 Purity ? 98 %
5.2.3 Purity ? 99 %
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Mesalamine Tablets
5.3.2 Mesalamine Capsules
5.3.3 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Purity ? 97 %
6.2.2 Purity ? 98 %
6.2.3 Purity ? 99 %
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Mesalamine Tablets
6.3.2 Mesalamine Capsules
6.3.3 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Purity ? 97 %
7.2.2 Purity ? 98 %
7.2.3 Purity ? 99 %
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Mesalamine Tablets
7.3.2 Mesalamine Capsules
7.3.3 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Purity ? 97 %
8.2.2 Purity ? 98 %
8.2.3 Purity ? 99 %
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Mesalamine Tablets
8.3.2 Mesalamine Capsules
8.3.3 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Purity ? 97 %
9.2.2 Purity ? 98 %
9.2.3 Purity ? 99 %
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Mesalamine Tablets
9.3.2 Mesalamine Capsules
9.3.3 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Syntese A/S
10.1.2 Corden Pharma Bergamo
10.1.3 Ipca Laboratories
10.1.4 Divis Laboratories
10.1.5 Erregierre SpA
10.1.6 Cambrex Corporation
10.1.7 Ishita Active Pharma Ingredients
10.1.8 Lasa Loboratory
10.1.9 PharmaZell
10.1.10 CTX Lifescience
10.1.11 YC Biotech (Jiangsu)
10.1.12 Xinxiang Tianfeng Fine Chemical
10.2 Mesalamine API Sales Date of Major Players (2017-2020e)
10.2.1 Syntese A/S
10.2.2 Corden Pharma Bergamo
10.2.3 Ipca Laboratories
10.2.4 Divis Laboratories
10.2.5 Erregierre SpA
10.2.6 Cambrex Corporation
10.2.7 Ishita Active Pharma Ingredients
10.2.8 Lasa Loboratory
10.2.9 PharmaZell
10.2.10 CTX Lifescience
10.2.11 YC Biotech (Jiangsu)
10.2.12 Xinxiang Tianfeng Fine Chemical
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL MESALAMINE API INDUSTRY
2.1 Summary about Mesalamine API Industry
2.2 Mesalamine API Market Trends
2.2.1 Mesalamine API Production & Consumption Trends
2.2.2 Mesalamine API Demand Structure Trends
2.3 Mesalamine API Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Purity ? 97 %
4.2.2 Purity ? 98 %
4.2.3 Purity ? 99 %
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Mesalamine Tablets
4.3.2 Mesalamine Capsules
4.3.3 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Purity ? 97 %
5.2.2 Purity ? 98 %
5.2.3 Purity ? 99 %
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Mesalamine Tablets
5.3.2 Mesalamine Capsules
5.3.3 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Purity ? 97 %
6.2.2 Purity ? 98 %
6.2.3 Purity ? 99 %
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Mesalamine Tablets
6.3.2 Mesalamine Capsules
6.3.3 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Purity ? 97 %
7.2.2 Purity ? 98 %
7.2.3 Purity ? 99 %
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Mesalamine Tablets
7.3.2 Mesalamine Capsules
7.3.3 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Purity ? 97 %
8.2.2 Purity ? 98 %
8.2.3 Purity ? 99 %
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Mesalamine Tablets
8.3.2 Mesalamine Capsules
8.3.3 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Purity ? 97 %
9.2.2 Purity ? 98 %
9.2.3 Purity ? 99 %
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Mesalamine Tablets
9.3.2 Mesalamine Capsules
9.3.3 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Syntese A/S
10.1.2 Corden Pharma Bergamo
10.1.3 Ipca Laboratories
10.1.4 Divis Laboratories
10.1.5 Erregierre SpA
10.1.6 Cambrex Corporation
10.1.7 Ishita Active Pharma Ingredients
10.1.8 Lasa Loboratory
10.1.9 PharmaZell
10.1.10 CTX Lifescience
10.1.11 YC Biotech (Jiangsu)
10.1.12 Xinxiang Tianfeng Fine Chemical
10.2 Mesalamine API Sales Date of Major Players (2017-2020e)
10.2.1 Syntese A/S
10.2.2 Corden Pharma Bergamo
10.2.3 Ipca Laboratories
10.2.4 Divis Laboratories
10.2.5 Erregierre SpA
10.2.6 Cambrex Corporation
10.2.7 Ishita Active Pharma Ingredients
10.2.8 Lasa Loboratory
10.2.9 PharmaZell
10.2.10 CTX Lifescience
10.2.11 YC Biotech (Jiangsu)
10.2.12 Xinxiang Tianfeng Fine Chemical
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
LIST OF TABLES
1.Table Mesalamine API Product Type Overview
2.Table Mesalamine API Product Type Market Share List
3.Table Mesalamine API Product Type of Major Players
4.Table Brief Introduction of Syntese A/S
5.Table Brief Introduction of Corden Pharma Bergamo
6.Table Brief Introduction of Ipca Laboratories
7.Table Brief Introduction of Divis Laboratories
8.Table Brief Introduction of Erregierre SpA
9.Table Brief Introduction of Cambrex Corporation
10.Table Brief Introduction of Ishita Active Pharma Ingredients
11.Table Brief Introduction of Lasa Loboratory
12.Table Brief Introduction of PharmaZell
13.Table Brief Introduction of CTX Lifescience
14.Table Brief Introduction of YC Biotech (Jiangsu)
15.Table Brief Introduction of Xinxiang Tianfeng Fine Chemical
16.Table Products & Services of Syntese A/S
17.Table Products & Services of Corden Pharma Bergamo
18.Table Products & Services of Ipca Laboratories
19.Table Products & Services of Divis Laboratories
20.Table Products & Services of Erregierre SpA
21.Table Products & Services of Cambrex Corporation
22.Table Products & Services of Ishita Active Pharma Ingredients
23.Table Products & Services of Lasa Loboratory
24.Table Products & Services of PharmaZell
25.Table Products & Services of CTX Lifescience
26.Table Products & Services of YC Biotech (Jiangsu)
27.Table Products & Services of Xinxiang Tianfeng Fine Chemical
28.Table Market Distribution of Major Players
29.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
30.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
31.Table Global Mesalamine API Market Forecast (Million USD) by Region 2021f-2026f
32.Table Global Mesalamine API Market Forecast (Million USD) Share by Region 2021f-2026f
33.Table Global Mesalamine API Market Forecast (Million USD) by Demand 2021f-2026f
34.Table Global Mesalamine API Market Forecast (Million USD) Share by Demand 2021f-2026f
1.Table Mesalamine API Product Type Overview
2.Table Mesalamine API Product Type Market Share List
3.Table Mesalamine API Product Type of Major Players
4.Table Brief Introduction of Syntese A/S
5.Table Brief Introduction of Corden Pharma Bergamo
6.Table Brief Introduction of Ipca Laboratories
7.Table Brief Introduction of Divis Laboratories
8.Table Brief Introduction of Erregierre SpA
9.Table Brief Introduction of Cambrex Corporation
10.Table Brief Introduction of Ishita Active Pharma Ingredients
11.Table Brief Introduction of Lasa Loboratory
12.Table Brief Introduction of PharmaZell
13.Table Brief Introduction of CTX Lifescience
14.Table Brief Introduction of YC Biotech (Jiangsu)
15.Table Brief Introduction of Xinxiang Tianfeng Fine Chemical
16.Table Products & Services of Syntese A/S
17.Table Products & Services of Corden Pharma Bergamo
18.Table Products & Services of Ipca Laboratories
19.Table Products & Services of Divis Laboratories
20.Table Products & Services of Erregierre SpA
21.Table Products & Services of Cambrex Corporation
22.Table Products & Services of Ishita Active Pharma Ingredients
23.Table Products & Services of Lasa Loboratory
24.Table Products & Services of PharmaZell
25.Table Products & Services of CTX Lifescience
26.Table Products & Services of YC Biotech (Jiangsu)
27.Table Products & Services of Xinxiang Tianfeng Fine Chemical
28.Table Market Distribution of Major Players
29.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
30.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
31.Table Global Mesalamine API Market Forecast (Million USD) by Region 2021f-2026f
32.Table Global Mesalamine API Market Forecast (Million USD) Share by Region 2021f-2026f
33.Table Global Mesalamine API Market Forecast (Million USD) by Demand 2021f-2026f
34.Table Global Mesalamine API Market Forecast (Million USD) Share by Demand 2021f-2026f
LIST OF FIGURES
1.Figure Global Mesalamine API Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Mesalamine API Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Mesalamine API Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Mesalamine API Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Mesalamine API Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Mesalamine API Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Mesalamine API Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Purity ? 97 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Purity ? 98 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Purity ? 99 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Mesalamine Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Mesalamine Capsules Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Purity ? 97 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Purity ? 98 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Purity ? 99 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Mesalamine Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Mesalamine Capsules Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Purity ? 97 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Purity ? 98 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Purity ? 99 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure Mesalamine Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure Mesalamine Capsules Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Purity ? 97 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Purity ? 98 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Purity ? 99 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Mesalamine Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Mesalamine Capsules Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Purity ? 97 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Purity ? 98 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure Purity ? 99 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Mesalamine Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Mesalamine Capsules Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Purity ? 97 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure Purity ? 98 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure Purity ? 99 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure Mesalamine Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure Mesalamine Capsules Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
71.Figure Mesalamine API Sales Revenue (Million USD) of Syntese A/S 2017-2020e
72.Figure Mesalamine API Sales Revenue (Million USD) of Corden Pharma Bergamo 2017-2020e
73.Figure Mesalamine API Sales Revenue (Million USD) of Ipca Laboratories 2017-2020e
74.Figure Mesalamine API Sales Revenue (Million USD) of Divis Laboratories 2017-2020e
75.Figure Mesalamine API Sales Revenue (Million USD) of Erregierre SpA 2017-2020e
76.Figure Mesalamine API Sales Revenue (Million USD) of Cambrex Cor
1.Figure Global Mesalamine API Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Mesalamine API Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Mesalamine API Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Mesalamine API Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Mesalamine API Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Mesalamine API Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Mesalamine API Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Purity ? 97 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Purity ? 98 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Purity ? 99 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Mesalamine Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Mesalamine Capsules Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Purity ? 97 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Purity ? 98 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Purity ? 99 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Mesalamine Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Mesalamine Capsules Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Purity ? 97 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Purity ? 98 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Purity ? 99 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure Mesalamine Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure Mesalamine Capsules Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Purity ? 97 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Purity ? 98 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Purity ? 99 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Mesalamine Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Mesalamine Capsules Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Purity ? 97 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Purity ? 98 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure Purity ? 99 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Mesalamine Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Mesalamine Capsules Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Purity ? 97 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure Purity ? 98 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure Purity ? 99 % Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure Mesalamine Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure Mesalamine Capsules Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
71.Figure Mesalamine API Sales Revenue (Million USD) of Syntese A/S 2017-2020e
72.Figure Mesalamine API Sales Revenue (Million USD) of Corden Pharma Bergamo 2017-2020e
73.Figure Mesalamine API Sales Revenue (Million USD) of Ipca Laboratories 2017-2020e
74.Figure Mesalamine API Sales Revenue (Million USD) of Divis Laboratories 2017-2020e
75.Figure Mesalamine API Sales Revenue (Million USD) of Erregierre SpA 2017-2020e
76.Figure Mesalamine API Sales Revenue (Million USD) of Cambrex Cor
